WINT : Insider Transactions for Windtree Therapeutics Inc

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

New Search

Get Insiders for :

Windtree Therapeutics Inc (WINT)

$0.16 0.00 (0.00%) as of 4:30 Thu 2/23

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

16,920,000

Market Cap:

2.77(M)

Last Volume:

25,688,722

Avg Vol:

24,206,070

52 Week Range:

$0.164 - $0.164

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Windtree Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of therapeutics to address unmet medical needs in acute care markets. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. In addition, Co. cardiovascular drug product candidates include rostafuroxin, for the treatment of hypertension in patients with a specific genetic profile. Co.'s pulmonary product candidate portfolio consists of a KL4 surfactant platform to address a range of serious respiratory conditions in children and adults.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	2,500	24,812
Total Buy Value	$0	$0	$2,250	$15,204
Total People Bought	0	0	1	2
Total Buy Transactions	0	0	1	8
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-08	2023-11-07	2023-05-09	2022-05-09

Adjust Filter Settings

Records found: 619

Page 10 of 25

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Templeton Mary B Esq

Senior VP, General Counsel

• – –

2012-12-31

$2.11

$4,127

I/I

1,956

19,111

Amick W Thomas

Chief Executive Officer

• – –

2012-12-31

$2.11

$4,252

I/I

2,015

15,957

Hoy Thomas

VP, Manufacturing Ops.

• – –

2012-12-31

$2.11

$4,250

I/I

2,014

16,124

Clayton Russell

Senior VP, R&D

• – –

2012-12-31

$2.11

$4,252

I/I

2,015

9,575

Cooper John G

President & CEO

• – –

2012-12-31

$2.11

$4,250

I/I

2,014

19,622

Miller Thomas F

Sr. VP - Chief Oper. Officer

• – –

2012-12-31

$2.11

$4,250

I/I

2,014

19,451

Cole Kathy

Senior VP, Human Resources

• – –

2012-09-30

$2.84

$4,251

I/I

1,497

19,331

Magee Michael L

VP, Quality Operations

• – –

2012-09-30

$2.84

$4,251

I/I

1,497

11,300

Tattory John Andrew

VP Finance, Controller

• – –

2012-09-30

$2.84

$3,899

I/I

1,373

16,722

Templeton Mary B Esq

Senior VP, General Counsel

• – –

2012-09-30

$2.84

$4,124

I/I

1,452

19,111

Amick W Thomas

Chief Executive Officer

• – –

2012-09-30

$2.84

$4,249

I/I

1,496

15,957

Hoy Thomas

VP, Manufacturing Ops.

• – –

2012-09-30

$2.84

$4,251

I/I

1,497

16,124

Clayton Russell

Senior VP, R&D

• – –

2012-09-30

$2.84

$4,249

I/I

1,496

9,575

Cooper John G

President & CEO

• – –

2012-09-30

$2.84

$4,249

I/I

1,496

19,622

Miller Thomas F

Sr. VP - Chief Oper. Officer

• – –

2012-09-30

$2.84

$4,249

I/I

1,496

19,451

Cole Kathy

Senior VP, Human Resources

• – –

2012-06-30

$2.32

$4,248

I/I

1,831

19,331

Magee Michael L

VP, Quality Operations

• – –

2012-06-30

$2.32

$4,250

I/I

1,832

11,300

Tattory John Andrew

VP Finance, Controller

• – –

2012-06-30

$2.32

$3,900

I/I

1,681

16,722

Templeton Mary B Esq

Senior VP, General Counsel

• – –

2012-06-30

$2.32

$4,125

I/I

1,778

19,111

Amick W Thomas

Chief Executive Officer

• – –

2012-06-30

$2.32

$4,250

I/I

1,832

15,957

Hoy Thomas

VP, Manufacturing Ops.

• – –

2012-06-30

$2.32

$4,250

I/I

1,832

16,124

Clayton Russell

Senior VP, R&D

• – –

2012-06-30

$2.32

$4,250

I/I

1,832

9,575

Cooper John G

President & CEO

• – –

2012-06-30

$2.32

$4,248

I/I

1,831

19,622

Miller Thomas F

Sr. VP - Chief Oper. Officer

• – –

2012-06-30

$2.32

$4,248

I/I

1,831

19,451

Magee Michael L

VP, Quality OperationsOfficer

• – –

2012-05-04

$0.00

I/I

5,364

619 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 10 of 25

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: